Skip to content
MarketScale
Creator HubsCorganics

Corganics

Corganics logo

Medical-grade CBD products developed with healthcare professionals.

Corganics is a physician-advised clinical cannabinoid company that develops THC-free, medical-grade CBD products formulated with input from healthcare professionals. Its products are designed for clinical and wellness settings where quality, dosing consistency, and safety documentation matter. On MarketScale, Corganics shares evidence-informed content on cannabinoid science, product development, and clinical applications for healthcare practitioners and health-conscious buyers.

2 episodes
Channel Brief·Corganics · 2 episodes
Updated Jun 18, 2025

Medical-grade CBD for providers demands rigorous verification

Corganics argues that clinical cannabinoid trust rests on FDA-registered manufacturing, third-party testing, and transparent THC elimination. Two episodes show how providers validate and deploy these products in real care settings.

Corganics believes healthcare professionals and their patients deserve cannabinoid products built on verifiable safety and clinical standards, not consumer-grade marketing. The channel demonstrates this through two concrete provider stories: Reggie Gatewood explaining Corganics' extraction precision to eliminate THC concern, and Kelly Hermans, CRNA, integrating Clinical CBD Drops into structured patient sleep protocols at Beautiphi Aesthetic Boutique.

Drawn from Verified, Tested, Trusted: How Corganics Ensur… and 1 more

Corganics uses hemp and a precise extraction process to eliminate THC concern entirely.

Reggie Gatewood, President of Corganics, Episode 1

By the numbers

2

named healthcare providers integrating Corganics into clinical practice

What the channel argues

InsightCorganics manufactures THC-free, medical-grade CBD in FDA-registered facilities with third-party validation.
InsightAdvanced Lipid Technology enhances bioavailability and consistency in Corganics' cannabinoid formulations.
InsightKelly Hermans, CRNA at Beautiphi, has integrated Corganics Clinical CBD Drops into patient sleep protocols via structured intake.
InsightProducts are formulated exclusively for healthcare professional use, not consumer retail.

What you'll learn

How a precise hemp extraction process and FDA registration create provider confidence in THC absence.
Why Advanced Lipid Technology matters: it improves how the body absorbs and uses CBD clinically.
How one CRNA operationalized CBD into her aesthetic practice through patient screening and personalized regimens.

What to do about it

Verify any cannabinoid supplier's FDA registration status and third-party lab testing before recommending to patients.
Develop a structured patient intake process to identify candidates for CBD and measure outcomes.
Understand the role of delivery technology (like lipid formulations) in clinical efficacy before choosing a product partner.

Who and what shows up

Reggie Gatewood

President of Corganics

Explained Corganics' precision extraction process and how it eliminates THC concern for clinical use.

Brooke Williams

DNP, CRNA, APNP, founder of Beauty Base Zero Aesthetics & Wellness

Asked critical questions about THC confidence in products, representing the provider perspective.

Kelly Hermans

CRNA, founder of Beautiphi Aesthetic Boutique

Demonstrated real-world clinical adoption by integrating Corganics Clinical CBD Drops into structured patient sleep protocols.

Questions this channel answers

Q

How can providers and patients be confident there is truly no THC in CBD products?

Corganics uses a precise extraction process starting with hemp, combined with FDA-registered manufacturing and third-party lab testing.

Verified, Tested, Trusted: How Corganics Ensures THC-Fre…
Q

What makes clinical CBD different from consumer CBD?

Clinical CBD is formulated exclusively for healthcare professional use, manufactured in FDA-registered facilities, validated through third-party testing, and enhanced with Advanced Lipid Technology for bioavailability.

Verified, Tested, Trusted: How Corganics Ensures THC-Fre…
Q

How do providers integrate CBD into patient care practice?

Kelly Hermans uses a structured intake process to identify patients with sleep concerns, then recommends personalized CBD regimens tailored to individual needs.

Corganics’ Clinical CBD Drops: Elevating Sleep and Patie…
Topics:Medical-grade CBD formulationsTHC-free cannabinoid productsAdvanced Lipid TechnologyFDA-registered manufacturingThird-party lab testing
Themes:Verification over assertion in clinical cannabinoid supplyProvider adoption as proof of clinical credibilityPrecision extraction and formulation technology as differentiator

Industry context

The full spectrum CBD market is projected to grow from $7.5 billion in 2026 to $19.2 billion by 2033, reflecting expanding clinical adoption and consumer interest in cannabinoid therapies.

Want a show like this for your brand?

MarketScale produces and distributes branded shows like Corganics for B2B companies.

Build your show →